Dissecting natural killer cell activation pathways through analysis of genetic mutations in human and mouse.
about
RasGRP1 is required for human NK cell functionSynergistic signals for natural cytotoxicity are required to overcome inhibition by c-Cbl ubiquitin ligaseMurine trophoblast cells induce NK cell interferon-gamma production through KLRK1DAP10 associates with Ly49 receptors but contributes minimally to their expression and function in vivoParasite-mediated upregulation of NK cell-derived gamma interferon protects against severe highly pathogenic H5N1 influenza virus infectionNK cells: immune cross-talk and therapeutic implications.Inherited DOCK2 Deficiency in Patients with Early-Onset Invasive Infections.Dual Requirement of Cytokine and Activation Receptor Triggering for Cytotoxic Control of Murine Cytomegalovirus by NK CellsStructural characteristics of zebrafish orthologs of adaptor molecules that associate with transmembrane immune receptors.Augmentation of natural cytotoxicity by chronic low-dose ionizing radiation in murine natural killer cells primed by IL-2Enhancing both CT imaging and natural killer cell-mediated cancer cell killing by a GD2-targeting nanoconstruct.Characterization of murine cytomegalovirus m157 from infected cells and identification of critical residues mediating recognition by the NK cell receptor Ly49H.Requirement and redundancy of the Src family kinases Fyn and Lyn in perforin-dependent killing of Cryptococcus neoformans by NK cellsSignal transduction during activation and inhibition of natural killer cells.Controlling natural killer cell responses: integration of signals for activation and inhibition.Significant functional heterogeneity among KIR2DL1 alleles and a pivotal role of arginine 245.Molecular checkpoints controlling natural killer cell activation and their modulation for cancer immunotherapy.Mechanisms of NK cell activation: CD4(+) T cells enter the scene.Utilizing cytokines to function-enable human NK cells for the immunotherapy of cancer.Redirected Primary Human Chimeric Antigen Receptor Natural Killer Cells As an "Off-the-Shelf Immunotherapy" for Improvement in Cancer Treatment.Human NKG2E is expressed and forms an intracytoplasmic complex with CD94 and DAP12.c-Cbl regulates MICA- but not ULBP2-induced NKG2D down-modulation in human NK cells.HLA-G inhibition of NK-cell cytolytic function is uncoupled from tumor cell lipid raft reorganization.Aberrant expression of NK cell receptors in Epstein-Barr virus-positive gammadelta T-cell lymphoproliferative disorders.Creation of the two isoforms of rodent NKG2D was driven by a B1 retrotransposon insertion.Fibroblastic reticular cells regulate intestinal inflammation via IL-15-mediated control of group 1 ILCs.Overexpression of CD85j in TNBC patients inhibits Cetuximab-mediated NK-cell ADCC but can be restored with CD85j functional blockade.Enavatuzumab, a Humanized Anti-TWEAK Receptor Monoclonal Antibody, Exerts Antitumor Activity through Attracting and Activating Innate Immune Effector Cells
P2860
Q24319921-41BA7C05-FE29-4A6F-957C-E6B9CF1D94A3Q33745662-C8FFA224-2DB9-498F-8A7E-9E4A8BA7C6E7Q34076708-9F37B0DA-225B-41A1-9925-70E950E02FCDQ35084254-9936B087-7B19-4383-A87F-98B15AD005E6Q35193034-34AC1DB7-06CD-41EF-A48E-2E2AED359683Q35591444-A1EF4797-68DC-4102-9860-271BCFCFBCCBQ35780432-9AD248F9-4433-4E61-80A4-BD99613799B1Q35882584-0ACF0F0A-F720-41B1-960B-09117A703F1EQ36103381-7AF4B034-E748-410F-8B92-C3FB055FE099Q36355756-C2DFDE51-18D0-4B05-961F-0FDCC2D3E3B8Q36795032-D961D72E-1659-4955-B2D4-4E4DF8183DCAQ36828793-3A460DA0-F92E-4F02-B23E-DB3241C752CDQ37264645-A2E6E885-7AF3-43B9-9EDE-4D6E17F2254DQ37378027-37F476B2-7F69-477B-8927-3E93433F4E11Q37404156-BB75DD98-D0FB-4ABE-A244-5ABB88627B82Q37472014-CC5A446E-CE67-4E82-BA05-E2D8FBF2EB0DQ37739485-CA245C8C-CFD3-4EF5-B63A-F05967CADA90Q37921196-D93AB75C-0FD3-424E-9174-7B1406F9DF34Q38233046-01A1AED2-3218-4611-86C2-5A27A04FE70CQ38666862-72925A48-E627-4764-B617-87EAFB78C298Q38984012-94C54EF4-DBC4-462D-A9FF-437810A29BF8Q38993228-4129EC64-B215-4AFC-A1D8-16ADE79F1D94Q39432611-B00026FE-54F7-4BFF-A99E-7DCDD219AF64Q39743670-AC7E8EBE-41A5-4C67-A47E-F5D178412389Q39869811-4A1C8954-B3F0-407C-9575-806762D59F19Q40474105-086A0C0B-79CC-4F99-BE3A-BB04F58C2426Q41333332-965F7684-F8AC-48C0-BBB5-5E55623CB4BFQ42718215-A0C8EC6B-1613-463F-AB89-84DC35B6C3FE
P2860
Dissecting natural killer cell activation pathways through analysis of genetic mutations in human and mouse.
description
2006 nî lūn-bûn
@nan
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
2006年论文
@zh
2006年论文
@zh-cn
name
Dissecting natural killer cell ...... mutations in human and mouse.
@ast
Dissecting natural killer cell ...... mutations in human and mouse.
@en
type
label
Dissecting natural killer cell ...... mutations in human and mouse.
@ast
Dissecting natural killer cell ...... mutations in human and mouse.
@en
prefLabel
Dissecting natural killer cell ...... mutations in human and mouse.
@ast
Dissecting natural killer cell ...... mutations in human and mouse.
@en
P2860
P1476
Dissecting natural killer cell ...... mutations in human and mouse.
@en
P2093
Ilaria Tassi
P2860
P304
P356
10.1111/J.1600-065X.2006.00463.X
P577
2006-12-01T00:00:00Z